SAN FRANCISCO, May 15, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury at the United States District Court for the District of Delaware. The jury found that Invitae's products using...
News Ticker
- [ June 4, 2023 ] Vial to Sponsor and Present at Clinical Trials at the Summit (CTS) 2023 in Park City, UT News
- [ June 4, 2023 ] Promising Data for Investigational Innovative Bispecific Ivonescimab Featured at ASCO 2023 News
- [ June 3, 2023 ] GRAIL Presents Real-World Experience With The Galleri® Multi-Cancer Early Detection Test At 2023 ASCO Annual Meeting News
- [ June 3, 2023 ] New PATHFINDER Study Analysis Demonstrates Efficient Diagnostic Resolution Following Multi-Cancer Early Detection Testing News
- [ June 3, 2023 ] ASCO: Gilead, Arcus inject a bit more hope into TIGIT tale with reduced risk of lung cancer progression News
Copyright © 2023 Biotech Networks, LLC
